These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 29360766)
1. Coffee Intake Decreases Risk of Postmenopausal Breast Cancer: A Dose-Response Meta-Analysis on Prospective Cohort Studies. Lafranconi A; Micek A; De Paoli P; Bimonte S; Rossi P; Quagliariello V; Berretta M Nutrients; 2018 Jan; 10(2):. PubMed ID: 29360766 [No Abstract] [Full Text] [Related]
2. Coffee Decreases the Risk of Endometrial Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies. Lafranconi A; Micek A; Galvano F; Rossetti S; Del Pup L; Berretta M; Facchini G Nutrients; 2017 Nov; 9(11):. PubMed ID: 29120352 [TBL] [Abstract][Full Text] [Related]
3. Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. Jiang W; Wu Y; Jiang X Gynecol Oncol; 2013 Jun; 129(3):620-9. PubMed ID: 23535278 [TBL] [Abstract][Full Text] [Related]
4. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. Grosso G; Micek A; Godos J; Sciacca S; Pajak A; Martínez-González MA; Giovannucci EL; Galvano F Eur J Epidemiol; 2016 Dec; 31(12):1191-1205. PubMed ID: 27699514 [TBL] [Abstract][Full Text] [Related]
5. Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. Oh JK; Sandin S; Ström P; Löf M; Adami HO; Weiderpass E Int J Cancer; 2015 Oct; 137(8):1979-89. PubMed ID: 25885188 [TBL] [Abstract][Full Text] [Related]
6. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Ganmaa D; Willett WC; Li TY; Feskanich D; van Dam RM; Lopez-Garcia E; Hunter DJ; Holmes MD Int J Cancer; 2008 May; 122(9):2071-6. PubMed ID: 18183588 [TBL] [Abstract][Full Text] [Related]
7. High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype. Lowcock EC; Cotterchio M; Anderson LN; Boucher BA; El-Sohemy A Nutr Cancer; 2013; 65(3):398-409. PubMed ID: 23530639 [TBL] [Abstract][Full Text] [Related]
8. Coffee Consumption and Risk of Biliary Tract Cancers and Liver Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies. Godos J; Micek A; Marranzano M; Salomone F; Rio DD; Ray S Nutrients; 2017 Aug; 9(9):. PubMed ID: 28846640 [TBL] [Abstract][Full Text] [Related]
9. Body mass index had different effects on premenopausal and postmenopausal breast cancer risks: a dose-response meta-analysis with 3,318,796 subjects from 31 cohort studies. Chen Y; Liu L; Zhou Q; Imam MU; Cai J; Wang Y; Qi M; Sun P; Ping Z; Fu X BMC Public Health; 2017 Dec; 17(1):936. PubMed ID: 29216920 [TBL] [Abstract][Full Text] [Related]
10. Does coffee, tea and caffeine consumption reduce the risk of incident breast cancer? A systematic review and network meta-analysis. Wang S; Li X; Yang Y; Xie J; Liu M; Zhang Y; Zhang Y; Zhao Q Public Health Nutr; 2021 Dec; 24(18):6377-6389. PubMed ID: 34311801 [TBL] [Abstract][Full Text] [Related]
11. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180 [TBL] [Abstract][Full Text] [Related]
12. Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies. Berretta M; Micek A; Lafranconi A; Rossetti S; Di Francia R; De Paoli P; Rossi P; Facchini G Oncotarget; 2018 Apr; 9(29):20807-20815. PubMed ID: 29755691 [TBL] [Abstract][Full Text] [Related]
13. Caffeinated and decaffeinated coffee consumption and melanoma risk: a dose-response meta-analysis of prospective cohort studies. Micek A; Godos J; Lafranconi A; Marranzano M; Pajak A Int J Food Sci Nutr; 2018 Jun; 69(4):417-426. PubMed ID: 28891369 [TBL] [Abstract][Full Text] [Related]
14. Coffee Consumption and Invasive Breast Cancer Incidence among Postmenopausal Women in the Cancer Prevention Study-II Nutrition Cohort. Gapstur SM; Gaudet MM; Wang Y; Hodge RA; Um CY; Hartman TJ; McCullough ML Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2383-2386. PubMed ID: 32817071 [TBL] [Abstract][Full Text] [Related]
15. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. Touillaud MS; Thiébaut AC; Fournier A; Niravong M; Boutron-Ruault MC; Clavel-Chapelon F J Natl Cancer Inst; 2007 Mar; 99(6):475-86. PubMed ID: 17374837 [TBL] [Abstract][Full Text] [Related]
16. Coffee consumption and risk of breast cancer: an up-to-date meta-analysis. Li XJ; Ren ZJ; Qin JW; Zhao JH; Tang JH; Ji MH; Wu JZ PLoS One; 2013; 8(1):e52681. PubMed ID: 23308117 [TBL] [Abstract][Full Text] [Related]
17. The association between coffee intake and breast cancer risk: a meta-analysis and dose-response analysis using recent evidence. Li Y; Ma L Ann Palliat Med; 2021 Apr; 10(4):3804-3816. PubMed ID: 33832295 [TBL] [Abstract][Full Text] [Related]
18. Associations of coffee/caffeine consumption with postmenopausal breast cancer risk and their interactions with postmenopausal hormone use. Yaghjyan L; McLaughlin E; Lehman A; Neuhouser ML; Rohan T; Lane DS; Snetselaar L; Paskett E Eur J Nutr; 2022 Oct; 61(7):3449-3459. PubMed ID: 35583696 [TBL] [Abstract][Full Text] [Related]
19. Coffee consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies. Li L; Gan Y; Wu C; Qu X; Sun G; Lu Z BMC Cancer; 2015 Oct; 15():733. PubMed ID: 26481317 [TBL] [Abstract][Full Text] [Related]
20. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis. Suzuki R; Orsini N; Saji S; Key TJ; Wolk A Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]